Английская Википедия:Hexahydrocannabiphorol

Материал из Онлайн справочника
Версия от 07:03, 21 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{Infobox drug | IUPAC_name = (6a''R'',10a''R'')-6,6,9-trimethyl-3-heptyl-6a,7,8,9,10,10a-hexahydrobenzo[''c'']chromen-1-ol | image = HHCP_structure.png | width = 240 <!--Clinical data--> | tradename = | legal_status = | routes_of_administration = <!--Pharmacokinetic data--> | metabolism = | elimination_half-life = | excretion = <!--Id...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Hexahydrocannabiphorol (HHCP, sometimes mistakenly referred to as hexahydroxycannabiphorol) is a semi-synthetic cannabinoid derivative which has been marketed since around 2021.[1][2] It is believed to be made from the hydrogenation of tetrahydrocannabiphorol (THCP). THCP is only reported as a trace component of cannabis in 2019.[3] HHCP was studied by Roger Adams as early as 1942.[4]

Legality

The legal status of hexahydrocannabinol and derivatives varies between countries, leading to widespread sale in some jurisdictions in Europe and the US.

In France, HHCP was banned in 2023.[5]

In Japan, Japanese Health Ministry announced that six synthetic cannabinoids with structures similar to HHCH, including HHCP, were to be banned from 6 January 2024.[6]

HHCP was banned in Slovakia as of 13 January 2024.Шаблон:Citation needed

See also

References

Шаблон:Reflist

Шаблон:Cannabinoids

Шаблон:Cannabinoid-stub